Avid Bioservices Inc (CDMO)

[PPHMVERYLONG]

"What can move the needle this week for PPHM is the company is presenting at two Cancer Immunotherapy Conferences. Jeff T. Hutchins, Ph.D., Peregrine’s vice president, preclinical research, will speak at Immunotherapy World 2016, being held January 25-27, 2016 in Washington, D.C. Additionally, Bruce Freimark, Ph.D., research director, preclinical oncology at Peregrine, will present at GTCBio’s 8th Immunotherapeutics & Immunomonitoring Conference, being held January 25-26, 2016 in San Diego, CA."


Worthless article. The needle did not move nor will it until we get definitve Phase III results which are at least a year away.